Clinical Trial

Exposure to Organochlorine Pollutants and Impact on Development in the Peripubertal Age in Guadeloupe

Study acronym: TIMOUNPUBERTY
Recruiting
View on ClinicalTrials.gov →
Summary
In the context of environmental pollution of the French West Indies by chlordecone and questions about health consequences, monitoring at the peripubertal age of children born alive in the TIMOUN cohort is justified in several respects: - existence of an already established mother-child cohort whose live-born children will reach peripubertal ages during the period 2020-2022; - opportunity to verify hypotheses put forward on the basis of toxicological data acquired in laboratory animals and the hormonal characteristics of chlordecone (endocrine disruptor); - strong societal demand for such research to be carried out because of concerns about the sensitivity of children and adolescents to the effects of environmental xenobiotics, in particular on sexual development and the age of puberty; - recommendation of the Scientific Council Chlordecone Inserm - InVS; specific action of the National Plan Chlordecone IV.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-10-20.
Trial Details
NCT Number NCT06653660
Lead Sponsor Centre Hospitalier Universitaire de la Guadeloupe
Collaborators: Institut National de la Santé Et de la Recherche Médicale, France
Conditions Prenatal Exposure, Postnatal Exposure
Enrollment 650 participants
Start Date 2022-12-19
Primary Completion 2026-12-19 (estimated)
Study Completion 2026-12-19 (estimated)
Updated on ClinicalTrials.gov 2025-11-17